Using a biological approach to activate a protein that may help treat obesity
Activation of C/EBP-β by mitohormesis as a therapy for obesity
This study is looking at how a special protein can help with weight loss and better metabolism, using a medication called adefovir dipivoxil, to find new ways to manage obesity safely and effectively.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11013315 on NIH RePORTER |
What this research studies
This research investigates how activating a specific protein called C/EBP-β can help in treating and preventing obesity. The study explores the effects of certain interventions, including a medication known as adefovir dipivoxil, on fat metabolism and energy expenditure. By using advanced techniques and animal models, researchers aim to understand how these interventions can lead to weight loss and improved metabolic health. The ultimate goal is to develop new, effective strategies for managing obesity without the serious side effects associated with current treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who are struggling with obesity and related metabolic conditions.
Not a fit: Patients who are not obese or do not have metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively reduce obesity and its associated health risks.
How similar studies have performed: Previous research has shown promising results in using biological mechanisms to address obesity, suggesting potential for success in this approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Bitto, Alessandro — University of Washington
- Study coordinator: Bitto, Alessandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.